EX 8-28 Cash to monthly cash expenses ratio Amicus Therapeutics, Inc., is a biopharmaceutical treatment of various diseases, including Parkinson's d the following financial data (in thousands) for three

FINANCIAL ACCOUNTING
10th Edition
ISBN:9781259964947
Author:Libby
Publisher:Libby
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
icon
Related questions
Question
Chapter 8 Internal Control and Cash
433
EX 8-28 Cash to monthly cash expenses ratio
OBJ. 8
Amicus Therapeutics, Inc., is a biopharmaceutical company that develops drugs for the
treatment of various diseases, including Parkinson's disease. Amicus Therapeutics reported
the following financial data (in thousands) for three recent years:
For Years Ended December 31
Year 3
Year 2
Year 1
hould
Cash and cash equivalents
Net cash flows from operations
x1 $79,749
$ 49,060
$ 187,026
(150,147)
(299,955)
(213,695)
a. Determine the monthly cash expenses for Year 3, Year 2, and Year 1. Round to one
decimal place.
b. Determine the ratio of cash to monthly cash expenses for Year 3, Year 2, and Year 1
as of December 31. Round to one decimal place.
Based on (a) and (b), comment on Amicus Therapeutics' ratio of cash to
С.
monthly operating expenses for Years 1, 2, and 3.
ms: Series A
Transcribed Image Text:Chapter 8 Internal Control and Cash 433 EX 8-28 Cash to monthly cash expenses ratio OBJ. 8 Amicus Therapeutics, Inc., is a biopharmaceutical company that develops drugs for the treatment of various diseases, including Parkinson's disease. Amicus Therapeutics reported the following financial data (in thousands) for three recent years: For Years Ended December 31 Year 3 Year 2 Year 1 hould Cash and cash equivalents Net cash flows from operations x1 $79,749 $ 49,060 $ 187,026 (150,147) (299,955) (213,695) a. Determine the monthly cash expenses for Year 3, Year 2, and Year 1. Round to one decimal place. b. Determine the ratio of cash to monthly cash expenses for Year 3, Year 2, and Year 1 as of December 31. Round to one decimal place. Based on (a) and (b), comment on Amicus Therapeutics' ratio of cash to С. monthly operating expenses for Years 1, 2, and 3. ms: Series A
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 4 steps

Blurred answer
Knowledge Booster
Cash Flow Statement Analysis
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
FINANCIAL ACCOUNTING
FINANCIAL ACCOUNTING
Accounting
ISBN:
9781259964947
Author:
Libby
Publisher:
MCG
Accounting
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Horngren's Cost Accounting: A Managerial Emphasis…
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
Intermediate Accounting
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
Financial and Managerial Accounting
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education